ArticleAging clinical and experimental research2026
Olfactory dysfunction as a marker of neurodegenerative disease in older adults.
Article in Aging clinical and experimental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly identification of neurodegenerative disorders in older adults remains a major challenge in geriatric clinical practice. Olfactory dysfunction is a common feature of several neurodegenerative disorders, particularly synucleinopathies, where it often precedes motor and cognitive symptoms, whereas in primary tauopathies olfactory function is usually preserved or only mildly impaired.
aimsThis study aimed to evaluate the diagnostic utility of the 12-item Sniffin' Sticks Test (SST-12) for identifying neurodegenerative disease in older adults.
methodsA total of 120 individuals were included: 72 with synucleinopathies, 23 with tauopathies, and 25 healthy controls. Olfactory function was assessed using the SST-12. Group differences were analyzed using ANOVA, Fisher's exact test, and post hoc procedures. Diagnostic accuracy was evaluated by ROC analysis.
resultsAnosmia occurred in 58.3% of synucleinopathy patients and 65.2% of tauopathy patients but was absent in controls (p < 0.0001). Women performed better on several items, while an age effect was observed only for odor T5 (banana) (p = 0.011). Subjective olfactory complaints had limited diagnostic value. The full SST-12 showed good accuracy in distinguishing patients from controls (AUC = 0.818; 95% CI 0.744-0.891). A shortened nine-odor version achieved slightly higher accuracy (AUC = 0.844; 95% CI 0.777-0.912). No significant difference was observed between synucleinopathies and tauopathies, including after adjustment for age and sex. DISCUSSION: These findings support the clinical usefulness of brief olfactory testing in older adults and highlight the potential of selected odor subsets to improve screening efficiency.
conclusionThe SST-12 is a sensitive and practical tool for detecting olfactory dysfunction in neurodegenerative disorders. Brief olfactory screening may represent a useful addition to routine geriatric assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.